However, in several other datasets, there were lowered C5orf34 levels in some cancers, including breast cancer, leukemia, lymphoma, ovarian cancer, brain, and central nervous system cancer, prostate cancer, and other cancers. This evidence concerns the gene C5orf34 and ovarian carcinoma.